The oncogenic pathways in mitochondrial-rich thyroid carcinomas are not clearly understood. To investigate the possible implication of mitochondrial abundance in the genesis of thyroid tumors, we have explored the gene expression profile of six oncocytic carcinomas and six mitochondrial-rich papillary carcinomas using cDNAmicroarray technology. A supervised approach allowed us to identify 83 genes differentially expressed in the two types of carcinoma. These genes were classified according to their ontologic profiles. Three genes, NOS3, alphaactinin-2 and alpha-catenin, suspected of playing a role in tumor genesis, were explored by quantitative RT-PCR analysis and immunohistochemistry. Of the 59 genes overexpressed in papillary carcinomas, 51% were involved in cell communication. Of the 24 genes overexpressed in oncocytic carcinomas, 84% were involved in mitochondrial and cellular metabolism. Our results suggest that mitochondrial respiratory chain complexes III and IV play a significant role in the regulation of reactive oxygen species production by oncocytic tumors.
Introduction
The WHO classification distinguishes between two types of differentiated thyroid cancer originating from follicular cells. Papillary thyroid carcinoma (PTC) is diagnosed on the basis of architectural and nuclear features, whereas follicular thyroid carcinoma is defined by capsular or vascular invasion in follicular epithelial cell neoplasms. Oncocytic tumors are epithelial tumors that affect a wide variety of human tissues but occur more frequently in the thyroid gland. Oncocytic thyroid carcinomas are defined as malignant epithelial tumors of the thyroid, composed exclusively or predominantly (75% or more) of oncocytic cells presenting cytoplasmic accumulations of dilated mitochondria. Several studies have confirmed the increased activity of the mitochondrial respiratory chain enzymes in these tumors (Ebner et al., 1991; Savagner et al., 2001a) . These lesions are mainly classified into oncocytic follicular carcinomas (also known as Hu¨rthle cell carcinomas). The identification of a Hu¨rthle cell papillary carcinoma subgroup suggests a close relationship between ordinary PTCs and oncocytic carcinomas (Cheung et al, 2000) . Also, ordinary PTCs present frequently an increase in mitochondrial content that may be involved in the tumor genesis (Haugen et al., 2003) .
There is no evidence to suggest that the etiology of oncocytic malignancies of thyroid is distinct from that of nononcocytic lesions. The somatic mutations in oncocytic malignancies of thyroid follicular cells are similar to those of the ordinary papillary and follicular carcinomas. Rearrangements involving the proto-oncogene RET as well as anomalies in the B-RAF, NTRK1, RAS, TC-1 and APC genes have been associated with the development of PTCs (Camiel et al., 1968; Fusco et al., 1987; Chua et al., 2000; Kimura et al., 2003) . Mutations in the RAS and PTEN genes, and a fusion between Pax8 and PPARg, have been implicated in the pathogenesis of follicular thyroid carcinomas (Kroll et al., 2000; Moretti et al., 2000) . Nevertheless, the basic mechanisms and signaling pathways involved in the genesis of oncocytic thyroid carcinomas are still poorly known.
The role of mitochondrial proliferation in cancer development has been evoked (Augenlicht et al., 1999) . A recent cDNA-microarray analysis of oncocytic thyroid tumors has demonstrated the profound modification of energy metabolism in oncocytoma (Baris et al., 2004) . In this study, the upregulation of genes coding for enzymes playing a role in the glycolysis, the tricarboxylic acid cycle and oxidative phosphorylation suggested the existence of an aerobic glycolytic mechanism in oncocytic adenomas and, unexpectedly, in oncocytic carcinomas as well. In another study, the upregulation of the PGC-1-related coactivator (PRC) indicated a close relationship between the regulation of oxidative phosphorylation, mitochondrial proliferation and cell proliferation in these tumors (Savagner et al., 2003) .
In the present study, we compare the expression profiles of six oncocytic follicular carcinomas and six ordinary mitochondrial-rich PTCs selected from a Figure 1 (a) Hierarchical average linkage clustering of the 83 most discriminating genes between follicular oncocytic and PTCs. Samples were obtained from 12 patients presenting sporadic thyroid tumors, six oncocytic follicular carcinomas and six ordinary mitochondrial-rich papillary carcinomas, diagnosed according to the WHO classification. All the samples were rendered anonymous before the study. We confirmed the rich mitochondrial content of the tumor cells by using a monoclonal antibody against a complex IV mitochondrial subunit of the respiratory chain (clone 113-1, Biogenex laboratories Inc., San Ramon, CA, USA). According to immunostaining scores, taking into account the signal localization and intensity and the percentage of positive cells, oncocytic carcinomas scored at 3 (more than 75% of staining), papillary carcinomas scored at 2 (between 25 and 75% of staining) and 3. Patients included three men and nine women, with a mean age of 48 years (range 19-75 years). The average tumor size for oncocytic carcinomas was 29715 mm (mean7s.d.; range 15-55 mm) and 23710 mm (mean7s.d.; range 10-40 mm) for PTCs. Gene expression was analysed with several other thyroid tumors by hybridization of nylon Hybond N þ membrane (Amersham Pharmacia Biotech, Little Chalfont, UK) cDNA arrays with radioactive probes, according to the protocols described elsewhere (Thieblemont et al., 2004) . The arrays displayed PCR products spotted from 6720 selected IMAGE human cDNA and control clones. The cDNA clones were selected because of their proven or putative implication in carcinogenesis (list available at http:// tagc.univ-mrs.fr/pub/). Total RNA was isolated from frozen thyroid samples using a standard guanidium isothiocyanate protocol (Trizol Reagent, Life Technologies, Gaithersburg, MD, USA). RNA integrity was determined on an RNA 6000 nano labchip (Agilent technologies, Waldbronn, Germany). cDNA from each thyroid sample was obtained from 5 mg of total RNA by simultaneous reverse transcription and [a-33 P]dCTP labeling as described elsewhere (http://tagc.univ-mrs.fr/pub/). Each cDNA was hybridized on an individual array prepared as described below. After washing, hybridization images were obtained by scanning with an imaging device (Fuji BAS 5000, Raytest, Paris, France). Signal intensities were quantified using ArrayGauge software (Fujifilm, Japan). Supervised analysis was used to highlight the most important genes discriminating oncocytic carcinomas from papillary carcinomas. The discriminating score (DS) was calculated as follows, DS ¼ (m 1 Àm 2 )/(s 1 þ s 2 ), where m 1 and s 1 , respectively, represent the mean and the s.d. of the expression levels of a given gene in sample subgroup 1, and m 2 and s 2 , respectively, represent the mean and the s.d. of the expression levels of the same gene in sample subgroup 2 (Golub et al., 1999) . Owing to the small number of samples in each group, we had to increase the error risk to 1% to select discriminant genes (Magrangeas et al., 2003) . This higher risk gives 3.2 false-positive genes meaning that, among 25 genes of our list (83/3.2), one gene could have been randomly selected. Clustering analysis was performed using the Pearson correlation and the average linkage method (Eisen et al., 1998) . (b) Gene function distribution (in %) according to the ontologic analysis. Black: papillary carcinomas; Gray: oncocytic carcinomas. Only genes with a known function were considered (N ¼ 77 genes). We searched for the biological processes in which the 77 genes with a known function were involved, according to the GO database. We used the statistical methods available on the FATIGO web server (http://fatigo.bioinfo.cnio.es, Al-Shahrour et al., 2004) to find over-and underrepresented GO terms in the two types of carcinomas. The statistical contrast was performed at the GO level 3, which constitutes the best compromise between information quality and the number of gene annoted Gene profiling of mitochondrial-rich thyroid tumors O Baris et al previous cDNA-microarray analysis on thyroid tumors (Baris et al., 2004) . Applying a supervised strategy, we have identified a set of genes that clearly differentiates between oncocytic follicular carcinomas and PTCs. Identification of these genes should improve our understanding of functional pathways involved in the genesis of the two types of mitochondrial-rich carcinomas.
Results and discussion
Complex targets prepared from several thyroid tumors were hybridized on microarrays containing PCR products from 6720 cDNA clones. After image quantification and normalization of microarray data, we searched for genes with consistent differential expression levels between the six follicular oncocytic carcinomas and the six ordinary PTCs. The 83 genes identified at 1% risk (24 of which were overexpressed in oncocytic carcinomas, and 59 overexpressed in PTCs) were hierarchically clustered as represented in Figure 1a . This set of genes allowed a clear distinction between the two classes of carcinomas, illustrating the efficiency of our supervised method. The genes overexpressed in oncocytic carcinomas are listed in Table 1 and those overexpressed in PTCs in Table 2 . Certain genes (COX7B, GLG1 and MMP2) were represented several times in the clusters, indicating the good reproducibility of the method. For PTCs, the overexpression of several genes (DUSP6, CCND1, TIMP1, CD44, MMP2) was in agreement with gene profiling and immunostaining studies, thus validating the accuracy of our present data (Huang et al., 2001; Maeta et al., 2001; Kim et al., 2002) . According to the Gene Ontology (GO) database, we search for the biological activity for 77 of the 83 genes with a known function, using statistics on FATIGO web server (Al-Shahrour et al., 2004) . The results are shown in Figure 1b . The 59 genes overexpressed in PTCs are mainly involved in cellular physiological process (52.94%) and cell communication (43.14%) such as cell-to-extracellular matrix and cell-to-cell adhesion. The expression of extracellular matrix components such as collagen and biglycan, as well as that of genes involved in adherent junctions (VCL, CDH3, CTNNA1) and tight junctions (TJP2), was higher in PTCs than in oncocytic carcinomas. Interestingly, we found that alpha-catenin and vinculin are overexpressed in PTCs, whereas alpha-actinin (ACTN2), a main component of the cytoskeleton, is underexpressed. Alpha-catenin plays an important role in mediating the binding between beta-catenin and the vinculin-alpha-actinin complex (Imamura et al., 1999) . Cytoplasmic and nuclear accumulation of alpha-and beta-catenin, related to high cyclin D1 expression, has been previously reported in PTCs (Ishigaki et al., 2002) . We used quantitative RT-PCR analysis and immunohistochemistry to analyse alpha-actinin and alpha-catenin expression in order to validate the strong difference in expression levels between the two types of carcinoma. We did not test the most differentially expressed gene named TIMP1 as it had already been validated as a PTC marker on the basis The 24 genes overexpressed in oncocytic vs papillary carcinomas are referenced by their HUGO abbreviations as used in Locus Link. The O/P ratio is the ratio between the median gene expression value in oncocytic carcinoma and that in papillary carcinoma (Pp0.01%)
Gene profiling of mitochondrial-rich thyroid tumors O Baris et al (Huang et al., 2001; Maeta et al., 2001) . The RT-PCR and immunochemistry study concerns a complementary set of seven samples for PTCs and three samples for oncocytic follicular carcinomas. The gene expression fold-change determined by quantitative RT-PCR analysis correlated well with the fold-change observed by microarray analysis. There were no major discrepancies as alpha-actinin was significantly overexpressed in oncocytic carcinomas (2.4-fold) and alpha-catenin was significantly overexpressed in papillary carcinomas (1.9-fold) ( Table 3 ). At the protein expression level, the most important difference concerns the expression of alpha-catenin. In oncocytic carcinomas, the protein expression was less intense than in PTCs, either situated in the cytoplasm or at the apical membrane, in contrast with a stronger expression in PTCs at the cellular border (Figure 2 ). Concerning alpha-actinin, a homogeneous cytoplasmic staining was found in oncocytic follicular carcinomas. In contrast, the expression in PTCs was more variable from one case to another. Alpha-actinin was either situated in the cytoplasm or condensed on the inside of the cellular membrane (Figure 2) . Then, the imbalance in actinin : -catenin ratio may either reflect or induce a disturbed cytoskeleton in PTCs.
Most of the genes overexpressed in oncocytic follicular carcinomas are involved in metabolic functions (83.33%). In addition, the proportion of genes involved in response to stress was greater in these tumors (21.05%) than in papillary carcinomas (7.84%). The analysis of the 24 genes overexpressed in oncocytic carcinomas suggested that the rate of oxidative metabolism in these tumors was higher than in PTCs. The GLUL gene involved in glutamine synthesis and several genes coding for respiratory chain subunits were overexpressed in oncocytic carcinomas compared to PTCs. Overexpression of the different respiratory chain complexes has been previously described for both types of carcinoma (Haugen et al., 2003; Baris et al., 2004) . We showed that complexes I and II were not differentially expressed in the two types of carcinoma. However, in spite of the abundance of mitochondria in the ordinary PTCs studied, the overexpression of complexes III and IV clearly distinguishes oncocytic carcinomas from PTCs.
We postulate that oncocytic follicular carcinomas tend to modulate ROS production by several mechanisms such as an increase in the electron flow rate through the overexpression of complexes III and IV, as well as the induction of glutathione, NO synthase and UCP2. The 59 genes overexpressed in papillary vs oncocytic carcinomas are referenced by their HUGO abbreviations as used in Locus Link. The P/O ratio is the ratio between the median gene expression value in papillary carcinoma and that in oncocytic carcinoma (Pp0.01%) The expression levels of three nuclear genes (NOS3, alpha-actinin and alpha-catenin) and one reference gene (b-actin) were measured on a LightCycler apparatus in five oncocytic follicular carcinomas and seven PTCs, different from those explored on the microarrays for 10/12 tumors. The amount of cDNA from the different genes was normalized by quantifying b-actin as described elsewhere (Savagner et al., 2001b) . The primers used for quantification were as follows: NOS3S, GAGCAGCTGCTGAGTCAGGC; NOS3R, CACTGTGATGGCCGAGCGAA; actinin S, GATCTGGACCATCATCCTTC; actinin R, GACGTACGTCATGATGGCTC; catenin S, CTGCTATGTTCCCTGAGACA; catenin R, CATGGTACGTACAATAGCAG. The reactions were performed following the manufacturer's recommendations (Roche, Mannheim, Germany).
For each run, a standard curve was generated using four 10-fold serial dilutions of an external standard. The different standards were generated by PCR of nuclear cDNA produced from a histologically normal thyroid, using the primers previously described and following the manufacturer's recommendations (Eurogentec, Seraing, Belgium). The PCR product was phenol-chloroform purified from low melting point agarose and cloned using the Topo TA Cloning kit (Invitrogen, Life Technologies, Groningen, The Netherlands). The recombinant was quantified by spectrophotometry. All samples were tested twice. A melting curve was systematically analysed to check for the specificity of the PCR products. Copy number/b-actin copy number Â 10
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The upregulation of complex IV may be associated with its specific function of regulating the production of free radicals. It has been shown that the potential-dependent slip in cytochrome c oxidase prevents the increase of ROS at the cellular level (Papa et al., 1997) . UCP2 has been reported to limit the production of ROS (Arsenijevic et al., 2000) . The expression of UCP2, as well as that of the subunits of complexes III and IV, is dependent on PRC, which is related to the PGC-1 family. We have shown that the overexpression of PRC in oncocytic tumors is related to the increased mitochondrial biogenesis induced by NRF-1 and TFAM and to UCP2 overexpression (Savagner et al., 2001a (Savagner et al., , 2003 . Increased expression of NRF-1 is confirmed in all the cases of oncocytic carcinomas in the present study. However, further studies on the effect of the phosphorylation level of the NRF-1 protein and of the interaction of NRF-1 with NRF-2 on the expression of these subunits would be necessary to elucidate the specific overexpression of the complexes III and IV of the respiratory chain. Recently, the induction of mitochondrial biogenesis has been associated with NOS3 overexpression through the induction of PGC-1 expression (Nisoli et al., 2003) . Figure 2 Immunoperoxidase staining of oncocytic follicular carcinomas and ordinary papillary carcinomas sections. A total of 26 formalin-fixed, paraffin-embedded thyroid tissue samples (12 tumors: five oncocytic follicular carinomas, seven papillary carcinomas, 14 normal) were used for tissue microarray construction as described (Kononen et al, 1998) . The oncocytic and the papillary carcinomas were arrayed separately. For each case, the array was composed of a double triplet (the tumor, the normal counterpart). Standard indirect immunoperoxidase procedures were used for immunohistochemistry. The primary antibodies were anti-nitric oxide synthase NOS3 (dilution 1 : 500, Calbiochem, San Diego, CA, USA), anti-alpha-actinin (dilution 1 : 400, Sigma, Saint-Louis, USA), anti-alpha-catenin (dilution 1 : 50, Calbiochem, San Diego, CA, USA). Diaminobenzidine was used as the chromogen and hematoxylin as the nuclear counterstain. Replacing the primary antibody by buffer performed negative controls. The analysis takes into account the cellular localization of the signal in addition to the intensity and the percentage of positive cells scored as 0, no staining; 1, less than 25%; 2, between 25 and 75%; and 3, equal or more than 75%. Magnification (a-f): Â 400. (a) NOS3 in oncocytic carcinomas, homogeneous staining of nearly all the tumor cells. Score 2, four samples and score 3, one sample. (b) NOS3 in papillary carcinomas, dense brown immunostaining at the apical pole of some cells. Score 2, four samples and score 3, three samples. (c) Alpha-actinin in oncocytic carcinomas, the staining occupied the whole cytoplasm in a homogeneous manner. Some brown granules are visible at the apical border. Score 2, three samples and score 3, two samples. (d) Alpha-actinin in papillary carcinomas, the staining is irregularly distributed all over the cytoplasm and concentrated at the inner part of the cellular membrane. Score 2, five samples and score 3, two samples. (e) Alpha-catenin in oncocytic carcinomas, a thin brown membrane staining. Score 1, four samples and score 2, one sample. (f) Alpha-catenin in papillary carcinomas, the cellular membrane staining is sharply defined. Score 2, two samples and score 3, five samples
